Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.

مواد مشابهة

• LMO2 and gene therapy for severe combined immunodeficiency.
  حسب: Fischer, A, وآخرون
  منشور في: (2004)
• The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
  حسب: McCormack, M, وآخرون
  منشور في: (2003)
• The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
  حسب: McCormack, M, وآخرون
  منشور في: (2010)
• Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
  حسب: Tse, E, وآخرون
  منشور في: (2004)
• LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
  حسب: Hacein-Bey-Abina, S, وآخرون
  منشور في: (2003)